Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which healthy lung tissue is gradually replaced by scar tissue.

Through the care of Dr. Narula and Dr. Matthias Loebe, Worrell was determined to be a good candidate and received his ...

Major advancements in pulmonary fibrosis treatment and critical warnings regarding both indoor air quality and scientific ...

Existing IPF treatments, including Boehringer’s recently approved Jascayd, slow disease progress rather than halt or reverse ...

The Department of Anesthesiology and Intensive Care Medicine at the Carl Gustav Carus University Hospital in Dresden and the TU Dresden Faculty of Medicine has conducted the world's largest study on ...

The Department of Anesthesiology and Intensive Care Medicine at the Carl Gustav Carus University Hospital in Dresden and the ...

A recent state-of-the-art review highlighted that despite significant advances, Pulmonary Hypertension (PH) patients continue ...

President Ferdinand Marcos Jr. declared the third Wednesday of June of every year as "National Pulmonary Rehabilitation Day," ...

President Ferdinand Marcos Jr. has designated the third Wednesday of June of each year as “National Pulmonary Rehabilitation ...

The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five years.PPF is a rare lung condition, more life-threatening than many ...

When Amy was first diagnosed with scleroderma, she never imagined it would lead to a lifelong journey with lung disease.

As it rolls out its US Technegas platform for detecting pulmonary embolisms, Cyclopharm is eyeing other indications including ...